| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3199062 | Journal of Allergy and Clinical Immunology | 2011 | 15 Pages |
Abstract
The described recombinant fusion proteins exhibit strongly reduced IgE-mediated allergenic activity, contain less than 40% of the Fel d 1 sequence, and thus lack many of the specific T-cell epitopes. Therefore they should represent safe vaccines for the treatment of cat allergy.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Katarzyna MSc, Margarete PhD, Birgit PhD, Vera Civaj, Katharina Blatt, Peter MD, Marianne MD, Hans PhD, Rudolf MD,